Cost effectiveness of a protocol using palivizumab in preterm infants
<p><strong>Objective:</strong> The main objective was to evaluate the cost-effectiveness of protocol use of palivizumab in premature established by consensus in our Hospital comparing it based on the recommendations of various Scientific Societies. As a secondary objective risk fac...
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Makale |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
Elsevier
2017-03-01
|
| Seri Bilgileri: | Farmacia Hospitalaria |
| Konular: | |
| Online Erişim: | http://www.aulamedica.es/fh/pdf/10565.pdf |